CA
LXRX icon

Crewe Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History

Crewe Advisors’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-150
Closed -$1K – 476
2020
Q4 		$1K Hold
150
– – ﹤0.01% 431
2020
Q3 		$0 Hold
150
– – ﹤0.01% 629
2020
Q2 		$0 Hold
150
– – ﹤0.01% 222
2020
Q1 		$0 Hold
150
– – ﹤0.01% 219
2019
Q4 		$1K Hold
150
– – ﹤0.01% 248
2019
Q3 		$0 Buy
+150
New +$464 ﹤0.01% 278

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return